This reduced activity in tumors contrasts with the enhanced PKC activity and expression found in models of neurodegenerative diseases such as AD or stroke (Table 1) (reviewed in Sun and Alkon (2014), Newton (2018a)). Here, PRRT2 is linked to Stroke.